Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter.
Sara BravacciniSara RavaioliMaria Maddalena TumedeiAndrea RoccaMichela PalleschiMaurizio PuccettiPaola ParrellaMattia AltiniRoberta MaltoniPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)